ribontx.comHealthcareFounded: 2015Funding to Date: $108.5MM
Ribon is a clinical-stage biotechnology company dedicated to the discovery and development of first-in-class small molecule inhibitors to block the fundamental ability of cancer cells to survive under stress.
View Enterprise Value for Ribon Therapeutics.